Compare EVCM & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVCM | LMAT |
|---|---|---|
| Founded | 2006 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 2.1B |
| IPO Year | 2021 | 2006 |
| Metric | EVCM | LMAT |
|---|---|---|
| Price | $8.01 | $80.39 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 5 |
| Target Price | $10.67 | ★ $105.80 |
| AVG Volume (30 Days) | 149.5K | ★ 253.1K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.93% |
| EPS Growth | ★ 145.45 | 30.57 |
| EPS | 0.09 | ★ 1.42 |
| Revenue | ★ $588,907,000.00 | $249,602,000.00 |
| Revenue This Year | $7.39 | $14.21 |
| Revenue Next Year | $5.84 | $8.88 |
| P/E Ratio | $87.56 | ★ $56.51 |
| Revenue Growth | N/A | ★ 13.53 |
| 52 Week Low | $6.21 | $78.27 |
| 52 Week High | $14.41 | $118.01 |
| Indicator | EVCM | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 41.96 | 40.64 |
| Support Level | N/A | $78.77 |
| Resistance Level | $12.52 | $83.71 |
| Average True Range (ATR) | 0.55 | 1.83 |
| MACD | -0.05 | 0.60 |
| Stochastic Oscillator | 52.43 | 41.04 |
EverCommerce Inc provides tailored Software-as-a-Service solutions for service-based small- and medium-sized businesses (SMBs) in-home services, health services, and fitness & wellness. The Company served more than 745,000 customers across three core verticals: EverPro for Home Services; EverHealth for Health Services; and EverWell for Wellness Services. Revenue is mostly generated from the United States. Operating in a single segment, their vertically-tailored SaaS offerings cater to SMBs' specialized demands, enabling them to automate processes, generate business, and enhance customer loyalty.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.